Septerna, Inc. — Investor Relations & Filings
Filings indexed
117
across all filing types
Latest filing
2026-04-30
Annual Report
Country
US
United States of America
Listing
US
SEPN
Septerna, Inc. is a clinical-stage biotechnology company that discovers and develops novel oral small molecule medicines targeting G protein-coupled receptors (GPCRs). The company leverages its proprietary Native Complex Platform™ to isolate and analyze GPCRs in their natural state, which facilitates the development of new therapies. Septerna is advancing a wholly-owned pipeline with an initial focus on endocrinology, immunology, inflammation, and metabolic diseases. One of its clinical programs involves SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator being evaluated for the treatment of mast cell-driven diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Septerna, Inc. (0001984086) (Filer) | 2026-04-30 | English | |
| 8-K - Septerna, Inc. (0001984086) (Filer) | 2026-04-13 | English | |
| 4 - SEPTERNA, INC. (0001984086) (Filer) | 2026-03-04 | English | |
| 8-K - SEPTERNA, INC. (0001984086) (Filer) | 2026-03-02 | English | |
| 4 - SEPTERNA, INC. (0001984086) (Filer) | 2026-02-20 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39218242 | ARS - Septerna, Inc. (0001984086) (Filer) | 2026-04-30 | English | ||
| 34413066 | 8-K - Septerna, Inc. (0001984086) (Filer) | 2026-04-13 | English | ||
| 32900856 | 4 - SEPTERNA, INC. (0001984086) (Filer) | 2026-03-04 | English | ||
| 32900858 | 8-K - SEPTERNA, INC. (0001984086) (Filer) | 2026-03-02 | English | ||
| 32900857 | 4 - SEPTERNA, INC. (0001984086) (Filer) | 2026-02-20 | English | ||
| 32277327 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32277400 | 4 Filing | 2026-02-10 | English | ||
| 32277353 | 4 Filing | 2026-02-10 | English | ||
| 32277321 | 4 Filing | 2026-02-10 | English | ||
| 32277319 | 4 Filing | 2026-02-10 | English | ||
| 32277318 | 4 Filing | 2026-02-10 | English | ||
| 32277317 | 4 Filing | 2026-02-10 | English | ||
| 32277312 | 4 Filing | 2026-02-10 | English | ||
| 32277307 | 4 Filing | 2026-02-10 | English | ||
| 13664402 | 3 | 2026-01-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alteogen Inc.
Biopharmaceutical firm developing biologics with proprietar…
|
196170 | KR | Professional, scientific and te… |
|
ALTERITY THERAPEUTICS LIMITED
Clinical-stage developer of disease-modifying therapies for…
|
ATH | AU | Professional, scientific and te… |
|
AlzeCure Pharma
Develops therapies for severe diseases, focusing on Alzheim…
|
ALZCUR | SE | Professional, scientific and te… |
|
AMPLIA THERAPEUTICS LIMITED
Clinical-stage developer of FAK inhibitors for solid tumors…
|
ATX | AU | Professional, scientific and te… |
|
ANAPTYSBIO, INC
Clinical-stage biotech developing immunology therapeutics f…
|
ANAB | US | Professional, scientific and te… |
|
ANATARA LIFESCIENCES LTD
Develops non-antibiotic gastrointestinal health solutions f…
|
ANR | AU | Professional, scientific and te… |
|
AngioLab, Inc.
Develops angiogenesis inhibitors for pharmaceuticals and he…
|
251280 | KR | Professional, scientific and te… |
|
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
Pharmaceutical CRO specializing in clinical trials, BE stud…
|
301520 | CN | Professional, scientific and te… |
|
Anixa Biosciences Inc
A clinical-stage biotech developing therapies and vaccines …
|
ANIX | US | Professional, scientific and te… |
|
Annovis Bio, Inc.
A clinical-stage drug platform company developing therapies…
|
ANVS | US | Professional, scientific and te… |
Septerna, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32396/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32396 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32396 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32396 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32396}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Septerna, Inc. (id: 32396)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.